Following Defense Secretary Pete Hegseth’s startling announcement in July that the US military would begin mandatory testosterone screening for personnel, the Pentagon released a clinical guidance document on September 2 outlining the new medically questionable policy.
The next day, though, the clinical guidance document disappeared, as did an accompanying statement by spokesperson Sean Parnell. The withdrawal was first reported by Reuters.
In a statement sent to Ars Technica, the Pentagon said that the document, titled “Clinical Guidance for Health and Human Performance Optimization,” had been temporarily rescinded on September 3 to allow for updates.
